Trial · NCT03910387
Results by group59
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 59
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Weight Stability | Group 1 (gemcitabine/nab-paclitaxel and telotristat ethyl) | -1.98 | Standard Deviation 6.87 | Percent weight change | |
| Weight Stability | Group 2 (gemcitabine/nab-paclitaxel) | -5.58 | Standard Deviation 5.89 | Percent weight change | |
| Change in 24-hr Urine 5-hydroxyindoleacetic Acid (5-HIAA) Levels | Group 1 (gemcitabine/nab-paclitaxel and telotristat ethyl) | Screening | 3 | Standard Deviation 261.67 | Milligrams |
| Change in 24-hr Urine 5-hydroxyindoleacetic Acid (5-HIAA) Levels | Group 2 (gemcitabine/nab-paclitaxel) | Screening | 4 | Standard Deviation 46.25 | Milligrams |
| Change in 24-hr Urine 5-hydroxyindoleacetic Acid (5-HIAA) Levels | Group 1 (gemcitabine/nab-paclitaxel and telotristat ethyl) | Cycle 1 Day 1 (Treatment day 0) | 8 | Standard Deviation 232.38 | Milligrams |
| Change in 24-hr Urine 5-hydroxyindoleacetic Acid (5-HIAA) Levels | Group 2 (gemcitabine/nab-paclitaxel) | Cycle 1 Day 1 (Treatment day 0) | 3 | Standard Deviation 44.87 | Milligrams |
| Change in 24-hr Urine 5-hydroxyindoleacetic Acid (5-HIAA) Levels | Group 1 (gemcitabine/nab-paclitaxel and telotristat ethyl) | Cycle 2 Day 1 (Treatment day 28) | 8 | Standard Deviation 58.63 | Milligrams |
| Change in 24-hr Urine 5-hydroxyindoleacetic Acid (5-HIAA) Levels | Group 2 (gemcitabine/nab-paclitaxel) | Cycle 2 Day 1 (Treatment day 28) | 2 | Standard Deviation 144.00 | Milligrams |
| Change in 24-hr Urine 5-hydroxyindoleacetic Acid (5-HIAA) Levels | Group 1 (gemcitabine/nab-paclitaxel and telotristat ethyl) | Cycle 3 Day 1 (Treatment day 56) | 7 | Standard Deviation 119.10 | Milligrams |
| Change in 24-hr Urine 5-hydroxyindoleacetic Acid (5-HIAA) Levels | Group 2 (gemcitabine/nab-paclitaxel) | Cycle 3 Day 1 (Treatment day 56) | 1 | Standard Deviation 273.00 | Milligrams |
| Change in 24-hr Urine 5-hydroxyindoleacetic Acid (5-HIAA) Levels | Group 1 (gemcitabine/nab-paclitaxel and telotristat ethyl) | Cycle 4 Day 1 (Treatment day 84) | 9 | Standard Deviation 91.56 | Milligrams |
| Change in 24-hr Urine 5-hydroxyindoleacetic Acid (5-HIAA) Levels | Group 2 (gemcitabine/nab-paclitaxel) | Cycle 4 Day 1 (Treatment day 84) | 1 | Standard Deviation 10.00 | Milligrams |
| Mid Arm Circumference (MAC) Measured in cm | Group 1 (gemcitabine/nab-paclitaxel and telotristat ethyl) | Screening | 24.35 | Standard Deviation 9.43 | cm |
| Mid Arm Circumference (MAC) Measured in cm | Group 2 (gemcitabine/nab-paclitaxel) | Screening | 34.88 | Standard Deviation 6.17 | cm |
| Mid Arm Circumference (MAC) Measured in cm | Group 1 (gemcitabine/nab-paclitaxel and telotristat ethyl) | Cycle 1 Day 1 | 24.39 | Standard Deviation 8.69 | cm |
| Mid Arm Circumference (MAC) Measured in cm | Group 2 (gemcitabine/nab-paclitaxel) | Cycle 1 Day 1 | 35.88 | Standard Deviation 5.86 | cm |
| Mid Arm Circumference (MAC) Measured in cm | Group 1 (gemcitabine/nab-paclitaxel and telotristat ethyl) | Cycle 2 Day 1 | 23.98 | Standard Deviation 7.28 | cm |
| Mid Arm Circumference (MAC) Measured in cm | Group 2 (gemcitabine/nab-paclitaxel) | Cycle 2 Day 1 | 35.5 | Standard Deviation 5.89 | cm |
| Mid Arm Circumference (MAC) Measured in cm | Group 1 (gemcitabine/nab-paclitaxel and telotristat ethyl) | Cycle 3 Day 1 | 25.71 | Standard Deviation 6.12 | cm |
| Mid Arm Circumference (MAC) Measured in cm | Group 2 (gemcitabine/nab-paclitaxel) | Cycle 3 Day 1 | 27 | Standard Deviation NA | cm |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03910387/results